@misc{indiciaec4bed514eda0,
  title = {Candidate methylation sites associated with endocrine therapy resistance in the TCGA ER+/HER2- breast cancer cohort},
  author = {Soleimani Dodaran, M. and Borgoni, S. and Sofyali, E. and Verschure, P. J. and Wiemann, S. and Moerland, P. D. and van Kampen, A. H. C.},
  year = {2019},
  doi = {10.1101/826198},
  url = {https://www.biorxiv.org/content/10.1101/826198v1},
  note = {Source identifier: 10.1101/826198}
}